Endolysins and Their Potential in Combating Bacterial Multidrug Resistance
Frontiers in Bioscience-Elite · 01.06.2026 · 18 (2)
DOI: 10.31083/fbe44070 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Bioscience-Elite, online erschienen am 01.06.2026. Verfasst von Olga I Guliy und 1 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biochemistry and Physiology of Plants and Microorganisms - Subdivision of the Federal State Budgetary Research Institution Saratov Feder…. Hauptthemen laut MEDLINE: Drug Resistance, Multiple, Bacterial, Anti-Bacterial Agents, Endopeptidases. Die Arbeit nennt 180 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Higher Education of the Russian Federation.
Abstract (Originalsprache)
Since the discovery of penicillin in 1928, more than a thousand antibiotics have been introduced into medical practice. Initially, the introduction of antibiotics revolutionized the treatment of infectious diseases. However, as antibiotics have been used repeatedly, scientists and clinicians have observed serious adverse consequences, most notably the emergence of bacterial resistance to antimicrobial agents. Of particular concern are multidrug-resistant pathogens, which are resistant to multiple antibiotic classes. As of 2024, antibiotic-resistant bacteria are directly responsible for approximately 1.27 million deaths worldwide. Thus, in response, possible new antibacterial agents are under investigation, including bacteriophages and the associated bacteriolytic enzymes. According to the World Health Organization (WHO), phage-based drugs are leading nonclassical antibiotics currently in clinical trials. Meanwhile, endolysins, as bacteriolytic phage enzymes, have emerged as promising antibacterial agents. This study reviews the key achievements and mechanisms of action of bacteriophage endolysins against bacterial infections, including biofilms, and discusses the therapeutic potential of endolysins in combating antibiotic resistance. Finally, the combined use of endolysins with other biomolecules and the application of artificial intelligence to address antimicrobial-resistant infections are also discussed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Biochemistry and Physiology of Plants and Microorganisms - Subdivision of the Federal State Budgetary Research Institution Saratov Federal Scientific Centre of the Russian Academy of Sciences (IBPPM RAS), 4…
Förderung
- Ministry of Science and Higher Education of the Russian Federation
Zitieren
APA
Guliy, O. I., & Karavaeva, O. A. (2026). Endolysins and Their Potential in Combating Bacterial Multidrug Resistance. Frontiers in Bioscience-Elite, 18(2). https://doi.org/10.31083/fbe44070
Vancouver
Guliy OI, Karavaeva OA. Endolysins and Their Potential in Combating Bacterial Multidrug Resistance. Frontiers in Bioscience-Elite. 2026;18(2). doi:10.31083/fbe44070
BibTeX
@article{Guliy2026,
author = {Guliy, Olga I and Karavaeva, Olga A},
title = {Endolysins and Their Potential in Combating Bacterial Multidrug Resistance},
journal = {Frontiers in Bioscience-Elite},
year = {2026},
volume = {18},
number = {2},
doi = {10.31083/fbe44070}
}
EUVIMED